FRIDAY, 11 SEPTEMBER 2026
Ticker

2.1 mn cars affected by VW scandal, says Audi

PTI

Frankfurt

Volkswagen's top-of-the-range automaker Audi said on Monday that 2.1 million of its diesel cars worldwide are fitted with the sophisticated software enabling them to cheat emission tests.

In Germany alone, 577,000 vehicles were affected and 13,000 in the United States, an Audi spokesman said.

In western Europe as a whole, the number was 1.42 million.

The models concerned were the A1, A3, A4, A6, Q3, Q5 and also the TT, the spokesman said.

Volkswagen sparked global outrage last week when it admitted that 11 million of its diesel cars are equipped with so-called defeat devices that activate pollution controls during tests but covertly turn them off when the car is on the road.

After the severe battering that VW shares took last week in the wake of the revelations, the stock continued to slide on Monday, shedding nearly seven percent.

According to German media reports at the weekend, Volkswagen ignored warnings from staff and a supplier years ago that the emission test rigging software was illegal.

German authorities meanwhile heaped pressure on the embattled corporate titan, demanding it set out a timeline by October 7 on how it will ensure its diesel cars meet national emission standards without using the cheat technology.

The spiralling scandal has badly tarnished VW's name, left it exposed to up to $18 billion (16 billion euros) in US fines, and wiped a third off its stock market value in a week.

Last Friday, the VW board tapped company insider Matthias Mueller - Chief of its luxury sports car brand Porsche - to steer the world's largest automaker out of the wreckage.

SHARE ON

DRL drugs launch on new drug launch

The Goan Network
Published Sep 28, 2015, 12:00 AM IST
SHARE ON

PTI Mumbai Shares of Dr Reddy's Laboratories (DRL) surged 6.5 per cent on Monday, after the company launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US market. The stock jumped 6.32 per cent to Rs 4,222.75 at the BSE. On the NSE, it rose by 6.46 per cent to Rs 4,226.90. The script was the top gainer among the blue-chip stocks on both Sensex and Nifty. In a BSE filing, DRL said "it has launched Esomeprazole magnesium delayed release…

READ MORE

Keep Reading — More from THE GOAN SPECIAL

3 more related stories queued · tap to continue reading

Home HOME News GOA NEWS Global GLOBAL GOENKAR Search SEARCH